SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-305871
Filing Date
2022-12-15
Accepted
2022-12-15 16:02:05
Documents
12
Period of Report
2022-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d429181d8k.htm   iXBRL 8-K 22132
  Complete submission text file 0001193125-22-305871.txt   142889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20221209.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20221209_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20221209_pre.xml EX-101.PRE 11269
6 EXTRACTED XBRL INSTANCE DOCUMENT d429181d8k_htm.xml XML 3340
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 221464782
SIC: 2835 In Vitro & In Vivo Diagnostic Substances